#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Immunodeficiency common variable Anti-HLA antibody test positive Oesophageal squamous cell carcinoma Lymphangioma Vascular calcification Chronic lymphocytic leukaemia Burkitt's lymphoma Endocrine ophthalmopathy Myelodysplastic syndrome with excess blasts Chondrodystrophy Porphyria non-acute Polycythaemia vera Hairy cell leukaemia recurrent Immune-mediated enterocolitis Sarcoma More trials…

    Learn about Rare Diseases

    Glomerulonephritis membranoproliferative – Treatment Primary biliary cholangitis – Diagnostics Cystic fibrosis Hypereosinophilic syndrome – Basic Information Stevens-Johnson syndrome Rett syndrome – Life with Disease Proteus syndrome – Trials in Disease Gaucher’s disease type III – Treatment Noonan syndrome – Life with Disease Sjogren’s syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Semaglutide SALICYLIC ACID Nystatin 68Ganota-Anti-Her2 Vhh1 Iberdomide Guselkumab R3R01 Methylprednisolone Garetosmab Methoxyflurane Diphenhydramine Lidocaine S227928 Amb-05X Donidalorsen Sargramostim Atropine Sulfate Monohydrate Vibosameran Itepekimab Buclizine Hydrochloride More therapies…

    Learn about Your Condition

    Plasma cell myeloma refractory Lower limb fracture Vulvovaginal pain Left ventricular dysfunction Infertility Procedural anxiety Oedema Abortion threatened Chronic hepatic failure Hypoxia Rhabdoid tumour Macular telangiectasia Raynaud's phenomenon Diverticulitis High-grade B-cell lymphoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of ustekinumab, adalimumab, and baricitinib for patients with folliculitis decalvans that is difficult to treat

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Adalimumab
    • Baricitinib
    • Ustekinumab
    France

  • Study comparing 7-day versus 14-day antifungal treatment for patients with uncomplicated candidemia using fluconazole, anidulafungin, or other medications

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Anidulafungin
    • Micafungin
    • Amphotericine B, Liposome
    France

  • Study of Ropivacaine and Dexamethasone Nerve Block for Patients with Acute Low Back Pain

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Back pain
    Investigated Drugs:
    • Ropivacaine Hydrochloride
    • Tramadol Hydrochloride
    • Dexamethasone Phosphate
    France

  • A study of pembrolizumab and lenvatinib for patients with high risk locally advanced cervical cancer after chemoradiotherapy and brachytherapy

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Cervix carcinoma
    Investigated Drugs:
    • Lenvatinib
    • Pembrolizumab
    The Netherlands

  • Testing rasburicase for preventing and treating kidney problems in adult patients with sepsis and high uric acid levels

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Sepsis
    Investigated Drugs:
    • Rasburicase
    France

  • Study comparing rocuronium dosing based on ideal versus real body weight for airway tube placement in patients with severe obesity

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Rocuronium Bromide
    • Propofol
    • Sodium Chloride
    Belgium
Previous Page
1 … 758 759 760 761 762 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!